Cargando…
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514132/ https://www.ncbi.nlm.nih.gov/pubmed/37695417 http://dx.doi.org/10.1007/s40261-023-01305-3 |
| _version_ | 1785108662086270976 |
|---|---|
| author | Fein, Luis Lazaretti, Nicolas Chuken, Yamil López Benfield, J. Rogelio González Ramírez Mano, Max S. Lobaton, Jose Korbenfeld, Ernesto Damian, Fernanda Lu, Dongrui R. Mori, Ave Patyna, Shem J. Franco, Sandra |
| author_facet | Fein, Luis Lazaretti, Nicolas Chuken, Yamil López Benfield, J. Rogelio González Ramírez Mano, Max S. Lobaton, Jose Korbenfeld, Ernesto Damian, Fernanda Lu, Dongrui R. Mori, Ave Patyna, Shem J. Franco, Sandra |
| author_sort | Fein, Luis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10514132 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105141322023-09-23 Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate Fein, Luis Lazaretti, Nicolas Chuken, Yamil López Benfield, J. Rogelio González Ramírez Mano, Max S. Lobaton, Jose Korbenfeld, Ernesto Damian, Fernanda Lu, Dongrui R. Mori, Ave Patyna, Shem J. Franco, Sandra Clin Drug Investig Correction Springer International Publishing 2023-09-11 2023 /pmc/articles/PMC10514132/ /pubmed/37695417 http://dx.doi.org/10.1007/s40261-023-01305-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Fein, Luis Lazaretti, Nicolas Chuken, Yamil López Benfield, J. Rogelio González Ramírez Mano, Max S. Lobaton, Jose Korbenfeld, Ernesto Damian, Fernanda Lu, Dongrui R. Mori, Ave Patyna, Shem J. Franco, Sandra Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate |
| title | Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate |
| title_full | Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate |
| title_fullStr | Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate |
| title_full_unstemmed | Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate |
| title_short | Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate |
| title_sort | correction: expanded access study of palbociclib plus letrozole for postmenopausal women with hr+/her2− advanced breast cancer in latin america for whom letrozole therapy is deemed appropriate |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514132/ https://www.ncbi.nlm.nih.gov/pubmed/37695417 http://dx.doi.org/10.1007/s40261-023-01305-3 |
| work_keys_str_mv | AT feinluis correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT lazarettinicolas correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT chukenyamillopez correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT benfieldjrogeliogonzalezramirez correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT manomaxs correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT lobatonjose correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT korbenfeldernesto correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT damianfernanda correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT ludongruir correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT moriave correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT patynashemj correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate AT francosandra correctionexpandedaccessstudyofpalbociclibplusletrozoleforpostmenopausalwomenwithhrher2advancedbreastcancerinlatinamericaforwhomletrozoletherapyisdeemedappropriate |